Cargando…

Mortality and treatment response amongst HIV-infected patients 50 years and older accessing antiretroviral services in South Africa

BACKGROUND: Little is known about the clinical presentation and outcomes amongst older HIV infected populations accessing ART in sub-Saharan Africa. We compared mortality amongst HIV infected patients accessing ART that were <  50 years to those ≥50 years in Kwa-Zulu Natal, South Africa. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Dawood, Halima, Hassan-Moosa, Razia, Zuma, Nonhlanhla-Yende, Naidoo, Kogieleum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894176/
https://www.ncbi.nlm.nih.gov/pubmed/29636023
http://dx.doi.org/10.1186/s12879-018-3083-z
_version_ 1783313447110311936
author Dawood, Halima
Hassan-Moosa, Razia
Zuma, Nonhlanhla-Yende
Naidoo, Kogieleum
author_facet Dawood, Halima
Hassan-Moosa, Razia
Zuma, Nonhlanhla-Yende
Naidoo, Kogieleum
author_sort Dawood, Halima
collection PubMed
description BACKGROUND: Little is known about the clinical presentation and outcomes amongst older HIV infected populations accessing ART in sub-Saharan Africa. We compared mortality amongst HIV infected patients accessing ART that were <  50 years to those ≥50 years in Kwa-Zulu Natal, South Africa. METHODS: We undertook a retrospective review of medical records of patients that accessed HIV services at the CAPRISA AIDS Treatment program (CAT) between June 2004 to December 2012 (N = 4003). HIV infected patients, 14 years or older were enrolled. All-cause mortality and treatment response to ART in those < 50 years to those ≥50 years were compared. A Kaplan-Meier curve and log-rank test were used to compare the cumulative probability of death between the two age groups with the primary endpoint being mortality. Statistical analysis was done using SAS (version 9.4.; SAS Institute Inc., Cary, NC, USA). RESULTS: Of 4003 individuals, 262 (6.5%) were ≥ 50 years (older group). The median age in those ≥50 years and <  50 year was 54.5 and 32.0 years, respectively. The younger group was mainly female (64.7%). There was no difference in mortality rate, between the older (6.9/100 person-years (py), 95% confidence interval (CI): 4.7–9.6) and younger group (5.3/100 py, 95% CI: 4.7–5.8) at 60 months (p = 0.137). In the multivariable model older patients had a significantly higher risk of death compared to younger patients. (hazard ratio (HR) 1.60, 95% CI: 1.08–2.39, p = 0.019).The rate of CD4+ cell count increase was higher in those < 50 years (β = 0.34, 95% CI: 0.19–0.50, p < 0.001) with no difference in viral suppression. The older group showed significantly higher prevalence of diabetes (6.3%) and hypertension (21.5%), p < 0.001. CONCLUSION: ART initiation in older HIV infected patients was associated with a higher mortality compared to those younger than 50 years. ART immunological response was less robust in older individuals. The increase in hypertension and diabetes among older patients suggests the need to restructure and integrate primary and specialized health care services into ART services. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-018-3083-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5894176
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58941762018-04-12 Mortality and treatment response amongst HIV-infected patients 50 years and older accessing antiretroviral services in South Africa Dawood, Halima Hassan-Moosa, Razia Zuma, Nonhlanhla-Yende Naidoo, Kogieleum BMC Infect Dis Research Article BACKGROUND: Little is known about the clinical presentation and outcomes amongst older HIV infected populations accessing ART in sub-Saharan Africa. We compared mortality amongst HIV infected patients accessing ART that were <  50 years to those ≥50 years in Kwa-Zulu Natal, South Africa. METHODS: We undertook a retrospective review of medical records of patients that accessed HIV services at the CAPRISA AIDS Treatment program (CAT) between June 2004 to December 2012 (N = 4003). HIV infected patients, 14 years or older were enrolled. All-cause mortality and treatment response to ART in those < 50 years to those ≥50 years were compared. A Kaplan-Meier curve and log-rank test were used to compare the cumulative probability of death between the two age groups with the primary endpoint being mortality. Statistical analysis was done using SAS (version 9.4.; SAS Institute Inc., Cary, NC, USA). RESULTS: Of 4003 individuals, 262 (6.5%) were ≥ 50 years (older group). The median age in those ≥50 years and <  50 year was 54.5 and 32.0 years, respectively. The younger group was mainly female (64.7%). There was no difference in mortality rate, between the older (6.9/100 person-years (py), 95% confidence interval (CI): 4.7–9.6) and younger group (5.3/100 py, 95% CI: 4.7–5.8) at 60 months (p = 0.137). In the multivariable model older patients had a significantly higher risk of death compared to younger patients. (hazard ratio (HR) 1.60, 95% CI: 1.08–2.39, p = 0.019).The rate of CD4+ cell count increase was higher in those < 50 years (β = 0.34, 95% CI: 0.19–0.50, p < 0.001) with no difference in viral suppression. The older group showed significantly higher prevalence of diabetes (6.3%) and hypertension (21.5%), p < 0.001. CONCLUSION: ART initiation in older HIV infected patients was associated with a higher mortality compared to those younger than 50 years. ART immunological response was less robust in older individuals. The increase in hypertension and diabetes among older patients suggests the need to restructure and integrate primary and specialized health care services into ART services. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-018-3083-z) contains supplementary material, which is available to authorized users. BioMed Central 2018-04-10 /pmc/articles/PMC5894176/ /pubmed/29636023 http://dx.doi.org/10.1186/s12879-018-3083-z Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Dawood, Halima
Hassan-Moosa, Razia
Zuma, Nonhlanhla-Yende
Naidoo, Kogieleum
Mortality and treatment response amongst HIV-infected patients 50 years and older accessing antiretroviral services in South Africa
title Mortality and treatment response amongst HIV-infected patients 50 years and older accessing antiretroviral services in South Africa
title_full Mortality and treatment response amongst HIV-infected patients 50 years and older accessing antiretroviral services in South Africa
title_fullStr Mortality and treatment response amongst HIV-infected patients 50 years and older accessing antiretroviral services in South Africa
title_full_unstemmed Mortality and treatment response amongst HIV-infected patients 50 years and older accessing antiretroviral services in South Africa
title_short Mortality and treatment response amongst HIV-infected patients 50 years and older accessing antiretroviral services in South Africa
title_sort mortality and treatment response amongst hiv-infected patients 50 years and older accessing antiretroviral services in south africa
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894176/
https://www.ncbi.nlm.nih.gov/pubmed/29636023
http://dx.doi.org/10.1186/s12879-018-3083-z
work_keys_str_mv AT dawoodhalima mortalityandtreatmentresponseamongsthivinfectedpatients50yearsandolderaccessingantiretroviralservicesinsouthafrica
AT hassanmoosarazia mortalityandtreatmentresponseamongsthivinfectedpatients50yearsandolderaccessingantiretroviralservicesinsouthafrica
AT zumanonhlanhlayende mortalityandtreatmentresponseamongsthivinfectedpatients50yearsandolderaccessingantiretroviralservicesinsouthafrica
AT naidookogieleum mortalityandtreatmentresponseamongsthivinfectedpatients50yearsandolderaccessingantiretroviralservicesinsouthafrica